What does CUSIP 56565P103 represent in this 13F holders report?

CUSIP 56565P103 is the security identifier for MPLT - MapLight Therapeutics, Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held MPLT - MapLight Therapeutics, Inc. - COMMON STOCK in Q1 2026?

9 institutional investors reported MPLT - MapLight Therapeutics, Inc. - COMMON STOCK for Q1 2026. Use the holders table for investor-level position and value details.

MapLight Therapeutics, Inc. - COMMON STOCK (MPLT)

CUSIP: 56565P103

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class: Equity / COMMON STOCK
Shares outstanding: 45,148,065
Total 13F shares: 18,346
Share change: +14,100
Total reported value: $373,035
Price per share: $20.33
Number of holders: 9
Value change: +$286,653
Number of buys: 5
Number of sells: 2

Quarterly Holders Quick Answers

What is CUSIP 56565P103?
CUSIP 56565P103 identifies MPLT - MapLight Therapeutics, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2025

Recent filing periods for CUSIP 56565P103:

Q1 2026 Q4 2025

Top shareholders of MPLT - MapLight Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Catalyst4, Inc.	13D/G 3/4/5	10%+ Owner	45%	19,697,464	$361,842,414	$0	28 Oct 2025	13D/G 3/4/5
Novo Holdings A/S	13F 13D/G 3/4/5	Company · 10%+ Owner	8.4% from 13D/G	3,686,622	$64,755,515	—	31 Dec 2025	13F 13D/G 3/4/5
Forbion Growth Opportunities Fund III Cooperatief U.A.	13D/G	—	7.1%	3,226,400	$61,527,448	$0	31 Dec 2025	13D/G
FCPM III SERVICES B.V.	13F	Company	7.1%	3,226,400	$56,671,716	—	31 Dec 2025	13F
T. Rowe Price Investment Management, Inc.	13D/G 13F	Company	6.2%	2,799,180	$53,380,363	$0	31 Dec 2025	13D/G 13F
GOLDMAN SACHS GROUP INC	13F	Company	4.3%	1,937,168	$34,026,356	—	31 Dec 2025	13F
BlackRock, Inc.	13F	Company	2.4%	1,095,514	$19,242,704	—	31 Dec 2025	13F
Nan Fung Group Holdings Ltd	13F	Company	2.2%	971,253	$17,060,059	—	31 Dec 2025	13F
5AM Venture Management, LLC	13F	Company	2.1%	950,011	$16,686,943	—	31 Dec 2025	13F
Sanofi	13F	Company	2%	912,041	$16,020,000	—	31 Dec 2025	13F
VANGUARD GROUP INC	13F	Company	1.9%	869,668	$15,275,718	—	31 Dec 2025	13F
Pivotal bioVenture Partners Investment Advisor LLC	13F	Company	1.4%	611,447	$10,743,124	—	31 Dec 2025	13F
PERCEPTIVE ADVISORS LLC	13F	Company	1.2%	550,000	$9,660,750	—	31 Dec 2025	13F
Velan Capital Investment Management LP	13F	Company	1.2%	522,305	$9,174,288	—	31 Dec 2025	13F
Siren, L.L.C.	13F	Individual	1%	450,000	$7,904,250	—	31 Dec 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.86%	389,026	$6,834,870	—	31 Dec 2025	13F
Vestal Point Capital, LP	13F	Company	0.85%	385,000	$6,762,525	—	31 Dec 2025	13F
BAKER BROS. ADVISORS LP	13F	Company	0.81%	364,705	$6,406,043	—	31 Dec 2025	13F
Jain Global LLC	13F	Company	0.73%	327,693	$5,755,928	—	31 Dec 2025	13F
Blue Owl Capital Holdings LP	13F	Company	0.72%	327,058	$5,744,774	—	31 Dec 2025	13F
STATE STREET CORP	13F	Company	0.51%	229,484	$4,030,886	—	31 Dec 2025	13F
LAZARD ASSET MANAGEMENT LLC	13F	Company	0.46%	207,494	$3,644,632	—	31 Dec 2025	13F
Board of Trustees of The Leland Stanford Junior University	13F	Company	0.44%	199,233	$3,499,527	—	31 Dec 2025	13F
CITADEL ADVISORS LLC	13F	Company	0.42%	190,139	$3,339,792	—	31 Dec 2025	13F
Freestone Grove Partners LP	13F	Company	0.41%	183,771	$3,227,938	—	31 Dec 2025	13F
Tetragon Partners GP Ltd	13F	Company	0.36%	164,525	$2,889,882	—	31 Dec 2025	13F
BNP Paribas Asset Management Holding S.A.	13F	Company	0.33%	147,930	$2,598,000	—	31 Dec 2025	13F
DAFNA Capital Management LLC	13F	Company	0.32%	143,764	$2,525,215	—	31 Dec 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.31%	138,427	$2,431,470	—	31 Dec 2025	13F
NORTHERN TRUST CORP	13F	Company	0.26%	119,557	$2,100,019	—	31 Dec 2025	13F
SEVEN GRAND MANAGERS, LLC	13F	Company	0.22%	100,000	$1,756,500	—	31 Dec 2025	13F
STEMPOINT CAPITAL LP	13F	Company	0.22%	100,000	$1,756,500	—	31 Dec 2025	13F
Burkehill Global Management, LP	13F	Company	0.17%	75,000	$1,317,375	—	31 Dec 2025	13F
Timothy John Garnett	3/4/5	Director	— mixed-class rows	89,253 mixed-class rows	$1,197,119	+$252,678	10 Feb 2026	3/4/5
AMERIPRISE FINANCIAL INC	13F	Company	0.15%	66,872	$1,174,606	—	31 Dec 2025	13F
DIADEMA PARTNERS LP	13F	Company	0.14%	63,791	$1,120,489	—	31 Dec 2025	13F
ORBIMED ADVISORS LLC	13F	Company	0.12%	56,000	$952,000	—	31 Dec 2025	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0.11%	47,840	$840,310	—	31 Dec 2025	13F
MARSHALL WACE, LLP	13F	Company	0.09%	39,659	$696,808	—	31 Dec 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.08%	37,820	$664,308	—	31 Dec 2025	13F
TD ASSET MANAGEMENT INC	13F	Company	0.08%	36,960	$649,202	—	31 Dec 2025	13F
Bank of New York Mellon Corp	13F	Company	0.08%	35,857	$629,828	—	31 Dec 2025	13F
BARCLAYS PLC	13F	Company	0.06%	26,415	$463,979	—	31 Dec 2025	13F
George Pavlov	3/4/5	Director	0.06%	25,000	$446,500	+$441,168	18 Feb 2026	3/4/5
MORGAN STANLEY	13F	Company	0.05%	23,222	$407,894	—	31 Dec 2025	13F
Persistent Asset Partners Ltd	13F	Company	0.05%	21,766	$382,320	—	31 Dec 2025	13F
Nuveen, LLC	13F	Company	0.04%	20,197	$354,760	—	31 Dec 2025	13F
Ghisallo Capital Management LLC	13F	Company	0.04%	20,000	$351,300	—	31 Dec 2025	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.04%	18,687	$328,237	—	31 Dec 2025	13F
UBS Group AG	13F	Company	0.04%	18,290	$321,264	—	31 Dec 2025	13F

Institutional Holders of MapLight Therapeutics, Inc. - COMMON STOCK (MPLT) as of Q1 2026

As of 31 Mar 2026, MapLight Therapeutics, Inc. - COMMON STOCK (MPLT) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,346 shares. The largest 9 holders included MARKET STREET WEALTH MANAGEMENT ADVISORS LLC, STRS OHIO, SBI Securities Co., Ltd., Sterling Capital Management LLC, Farther Finance Advisors, LLC, GAMMA Investing LLC, Versant Capital Management, Inc, Root Financial Partners, LLC, and True Wealth Design, LLC. This page lists 9 institutional shareholders reporting positions in this security for the Q1 2026 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

Q1 2026 holders

Holder diff

-65

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2026 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.